Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results

OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U followed by 100.000 U/hour. Short- and long-term results were assessed by radioscopy and echocardiography. RESULTS: Of the 17 patients, 12 had mechanical double-disk prostheses (4 aortic, 6 mitral, 2 tricuspid), 4 had single-disk prostheses (2 aortic, 1 mitral, and 1 tricuspid), and 1 had a tricuspid bioprosthesis. The success rate was 64.8%, the partial success rate was 17.6%, and the nonsuccess rate was 17.6%. All patients with a double-disk prosthesis responded, completely or partially, to the treatment. None of the patients with a single-disk prosthesis had complete resolution of the thrombosis. The time of streptokinase infusion ranged from 6 to 80 hours (mean of 56 h). The mortality rate due to the use of streptokinase was 5.8% and was secondary to cerebral bleeding. During streptokinase infusion, 3 (17.6%) embolic episodes occurred as follows: 1 cerebral, 1 peripheral, and 1 coronary. The rethrombosis index was 33% in a mean follow-up of 42 months. CONCLUSION: The use of fibrinolytic agents was effective and relatively safe in patients with primary thrombosis of a double-disk prosthesis. A fatal hemorrhagic complication occurred in 1 (5.8%) patient, and embolic complications occurred in 3 (17.6%) patients. In a mean 42-month follow-up, 67% of the patients were free from rethrombosis.

Saved in:
Bibliographic Details
Main Authors: Ramos,Auristela I. O., Ramos,Rui F., Togna,Dorival J. D., Arnoni,Antoninho S., Staico,Rodolfo, Galo,Mercedes M., Meneghelo,Zilda M.
Format: Digital revista
Language:English
Published: Sociedade Brasileira de Cardiologia - SBC 2003
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003001200006
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0066-782X2003001200006
record_format ojs
spelling oai:scielo:S0066-782X20030012000062003-11-05Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term resultsRamos,Auristela I. O.Ramos,Rui F.Togna,Dorival J. D.Arnoni,Antoninho S.Staico,RodolfoGalo,Mercedes M.Meneghelo,Zilda M. fibrinolytic therapy thrombosis streptokinase cardiac valvular prostheses OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U followed by 100.000 U/hour. Short- and long-term results were assessed by radioscopy and echocardiography. RESULTS: Of the 17 patients, 12 had mechanical double-disk prostheses (4 aortic, 6 mitral, 2 tricuspid), 4 had single-disk prostheses (2 aortic, 1 mitral, and 1 tricuspid), and 1 had a tricuspid bioprosthesis. The success rate was 64.8%, the partial success rate was 17.6%, and the nonsuccess rate was 17.6%. All patients with a double-disk prosthesis responded, completely or partially, to the treatment. None of the patients with a single-disk prosthesis had complete resolution of the thrombosis. The time of streptokinase infusion ranged from 6 to 80 hours (mean of 56 h). The mortality rate due to the use of streptokinase was 5.8% and was secondary to cerebral bleeding. During streptokinase infusion, 3 (17.6%) embolic episodes occurred as follows: 1 cerebral, 1 peripheral, and 1 coronary. The rethrombosis index was 33% in a mean follow-up of 42 months. CONCLUSION: The use of fibrinolytic agents was effective and relatively safe in patients with primary thrombosis of a double-disk prosthesis. A fatal hemorrhagic complication occurred in 1 (5.8%) patient, and embolic complications occurred in 3 (17.6%) patients. In a mean 42-month follow-up, 67% of the patients were free from rethrombosis.info:eu-repo/semantics/openAccessSociedade Brasileira de Cardiologia - SBCArquivos Brasileiros de Cardiologia v.81 n.4 20032003-10-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003001200006en10.1590/S0066-782X2003001200006
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Ramos,Auristela I. O.
Ramos,Rui F.
Togna,Dorival J. D.
Arnoni,Antoninho S.
Staico,Rodolfo
Galo,Mercedes M.
Meneghelo,Zilda M.
spellingShingle Ramos,Auristela I. O.
Ramos,Rui F.
Togna,Dorival J. D.
Arnoni,Antoninho S.
Staico,Rodolfo
Galo,Mercedes M.
Meneghelo,Zilda M.
Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
author_facet Ramos,Auristela I. O.
Ramos,Rui F.
Togna,Dorival J. D.
Arnoni,Antoninho S.
Staico,Rodolfo
Galo,Mercedes M.
Meneghelo,Zilda M.
author_sort Ramos,Auristela I. O.
title Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
title_short Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
title_full Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
title_fullStr Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
title_full_unstemmed Fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
title_sort fibrinolytic therapy for thrombosis in cardiac valvular prosthesis short and long term results
description OBJECTIVE: To assess the short- and long-term results of the use of streptokinase (SK) for the treatment of thromboses in cardiac valvular prostheses. METHODS: Seventeen patients with cardiac prosthetic thrombosis diagnosed by clinical, echocardiographic, and radioscopic findings underwent fibrinolytic treatment with a streptokinase bolus of 250,000 U followed by 100.000 U/hour. Short- and long-term results were assessed by radioscopy and echocardiography. RESULTS: Of the 17 patients, 12 had mechanical double-disk prostheses (4 aortic, 6 mitral, 2 tricuspid), 4 had single-disk prostheses (2 aortic, 1 mitral, and 1 tricuspid), and 1 had a tricuspid bioprosthesis. The success rate was 64.8%, the partial success rate was 17.6%, and the nonsuccess rate was 17.6%. All patients with a double-disk prosthesis responded, completely or partially, to the treatment. None of the patients with a single-disk prosthesis had complete resolution of the thrombosis. The time of streptokinase infusion ranged from 6 to 80 hours (mean of 56 h). The mortality rate due to the use of streptokinase was 5.8% and was secondary to cerebral bleeding. During streptokinase infusion, 3 (17.6%) embolic episodes occurred as follows: 1 cerebral, 1 peripheral, and 1 coronary. The rethrombosis index was 33% in a mean follow-up of 42 months. CONCLUSION: The use of fibrinolytic agents was effective and relatively safe in patients with primary thrombosis of a double-disk prosthesis. A fatal hemorrhagic complication occurred in 1 (5.8%) patient, and embolic complications occurred in 3 (17.6%) patients. In a mean 42-month follow-up, 67% of the patients were free from rethrombosis.
publisher Sociedade Brasileira de Cardiologia - SBC
publishDate 2003
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0066-782X2003001200006
work_keys_str_mv AT ramosauristelaio fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults
AT ramosruif fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults
AT tognadorivaljd fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults
AT arnoniantoninhos fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults
AT staicorodolfo fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults
AT galomercedesm fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults
AT meneghelozildam fibrinolytictherapyforthrombosisincardiacvalvularprosthesisshortandlongtermresults
_version_ 1756381492196409344